Wednesday, July 8, 2026
🇺🇸 FDA

Patent directory · USPTO A61K / A61P

Patents matching “GALECTIN THERAPEUTICS, INC.”

17 pharma patents match "GALECTIN THERAPEUTICS, INC." in our USPTO index (A61K/A61P) — applicant, grant date, expiration, and drug links.

Matches 17
Index total 30,257
Page 1 / 1

Quick answer

This filtered view shows 17 pharmaceutical patents matching "GALECTIN THERAPEUTICS, INC." in our USPTO PatentsView index (CPC A61K/A61P). Search matches patent number, title, applicant, and CPC classification codes.

Patent results

17 results for “GALECTIN THERAPEUTICS, INC.” · 30,257 patents in full index Clear search

  1. US 11413303

    Methods for treatment of arthritis

    GALECTIN THERAPEUTICS, INC. · Granted Aug 16, 2022 · Expires Aug 11, 2042

    granted

  2. US 10799525

    Composition of novel carbohydrate drug for treatment of human diseases

    GALECTIN THERAPEUTICS, INC. · Granted Oct 13, 2020 · Expires Oct 8, 2040

    granted

  3. US 10744154

    Galactose-pronged polysaccharides in a formulation for antifibrotic therapies

    GALECTIN THERAPEUTICS, INC. · Granted Aug 18, 2020 · Expires Aug 13, 2040

    granted

  4. US 10420793

    Composition of novel carbohydrate drug for treatment of human diseases

    GALECTIN THERAPEUTICS, INC. · Granted Sep 24, 2019 · Expires Sep 19, 2039

    granted

  5. US 9974802

    Composition of novel carbohydrate drug for treatment of human diseases

    GALECTIN THERAPEUTICS, INC. · Granted May 22, 2018 · Expires May 17, 2038

    granted

  6. US 9968631

    Method for treatment of pulmonary fibrosis

    GALECTIN THERAPEUTICS, INC. · Granted May 15, 2018 · Expires May 10, 2038

    granted

  7. US 9763974

    Galacto-rhamnogalacturonate compositions for the treatment of diseases associated with elevated inducible nitric oxide synthase

    GALECTIN THERAPEUTICS, INC. · Granted Sep 19, 2017 · Expires Sep 14, 2037

    granted

  8. US 9649327

    Composition of novel carbohydrate drug for treatment of human diseases

    GALECTIN THERAPEUTICS, INC. · Granted May 16, 2017 · Expires May 11, 2037

    granted

  9. US 9339515

    Method for treatment of pulmonary fibrosis

    GALECTIN THERAPEUTICS, INC. · Granted May 17, 2016 · Expires May 12, 2036

    granted

  10. US 9200090

    Galactose-pronged polysaccharides in a formulation for antifibrotic therapies

    GALECTIN THERAPEUTICS, INC. · Granted Dec 1, 2015 · Expires Nov 26, 2035

    granted

  11. US 8962824

    Composition of novel carbohydrate drug for treatment of human diseases

    GALECTIN THERAPEUTICS, INC. · Granted Feb 24, 2015 · Expires Feb 19, 2035

    granted

  12. US 8871925

    Compositions of novel carbohydrate drug for treatment of human diseases

    GALECTIN THERAPEUTICS, INC. · Granted Oct 28, 2014 · Expires Oct 23, 2034

    granted

  13. US 8828971

    Galactose-pronged carbohydrate compounds for the treatment of diabetic nephropathy and associated disorders

    GALECTIN THERAPEUTICS, INC. · Granted Sep 9, 2014 · Expires Sep 4, 2034

    granted

  14. US 8722645

    Galactose-pronged polysaccharides in a formulation for antifibrotic therapies

    GALECTIN THERAPEUTICS, INC. · Granted May 13, 2014 · Expires May 8, 2034

    granted

  15. US 8658787

    Galacto-rhamnogalacturonate compositions for the treatment of non-alcoholic steatohepatitis and non-alcoholic fatty liver disease

    GALECTIN THERAPEUTICS, INC. · Granted Feb 25, 2014 · Expires Feb 20, 2034

    granted

  16. US 8367638

    Galactose-pronged polysaccharides in a formulation for antifibrotic therapies

    GALECTIN THERAPEUTICS, INC. · Granted Feb 5, 2013 · Expires Jan 31, 2033

    granted

  17. US 8236780

    Galactose—pronged polysaccharides in a formulation for antifibrotic therapies

    GALECTIN THERAPEUTICS, INC. · Granted Aug 7, 2012 · Expires Aug 2, 2032

    granted

Drug approvals, clinical trials, M&A, event intelligence, and company updates — weekly.

Customize topics & region
Topics
Region

No spam. Unsubscribe anytime. See our privacy policy.